Reply: Impact of Remdesivir on Heart Rate and Bradycardia Incidence Among Hospitalized Adults With COVID-19

Abstract

Get full access to this article

View all access options for this article.

References

Daungsupawong

Wiwanitkit

Comment: impact of remdesivir on heart rate and bradycardia incidence among hospitalized adults with COVID-19. Ann Pharmacother 2025.

Kufel

Zagoria

Seabury

, et al. Impact of remdesivir on heart rate and bradycardia incidence among hospitalized adults with COVID-19. Ann Pharmacother. Published online April 23, 2025. doi:10.1177/10600280251327154

Gubitosa

Kakar

Gerula

, et al. Marked sinus bradycardia associated with remdesivir in COVID-19: a case and literature review. JACC Case Rep. 2020;2(14):2260-2264. doi:10.1016/j.jaccas.2020.08.025

Ching

Lee

Remdesivir-associated bradycardia. BMJ Case Rep. 2021;14(9):e245289. doi:10.1136/bcr-2021-245289

Donepudi

Agarwal

Thakur

Severe bradycardia leading to hemodynamic instability associated with remdesivir use in a patient with COVID-19 pneumonia. Case Rep Crit Care. 2022;2022:8807957. doi:10.1155/2022/8807957

Attena

Albani

Maraolo

, et al. Remdesivir-induced bradycardia in COVID-19: a single center prospective study. Circ Arrhythm Electrophysiol. 2021;14(7):e009811. doi:10.1161/CIRCEP.121.009811

Pantazopoulos

Mavrovounis

Dimeas

, et al. Remdesivir-induced bradycardia is not associated with worse outcome in patients with COVID-19: a retrospective analysis. Am J Cardiovasc Drugs. 2022;22(6):705-710. doi:10.1007/s40256-022-00547-4

Pallotto

Blanc

Esperti

, et al. Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19). J Infect. 2021;83(2):237-279. doi:10.1016/j.jinf.2021.05.025

Touafchia

Bagheri

Carrié

, et al. Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns. Clin Microbiol Infect. 2021;27(5):791e5-791e8. doi:10.1016/j.cmi.2021.02.013

10.

Devgun

Zhang

Brent

, et al. Identification of bradycardia following remdesivir administration through the US food and drug administration American college of medical toxicology COVID-19 toxic pharmacovigilance project. JAMA Netw Open. 2023;6(2):e2255815. doi:10.1001/jamanetworkopen.2022.55815

11.

Filtz

Carandina

Fasiello

, et al. Remdesivir-induced bradycardia in patients hospitalized with SARS-CoV2 infection: a possible vagally-mediated mechanism. Intern Emerg Med. 2023;18(2):359-366. doi:10.1007/s11739-022-03168-6